Exercise Training and Cardiovascular Function in Obesity and in Type 2 Diabetes

November 14, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Effects of an Individualized Training Program on Cardiovascular Function at Rest and During Exercise in Obese and in Type 2 Diabetic Subjects

Obesity and diabetes increase cardiovascular risk by complex and incompletely known mechanisms. The aims of this study are :

  1. to compare cardiac and vascular functions at rest and during exercise in 4 groups of age-matched men, without cardiovascular diseases but exhibiting increasing cardiovascular risk: trained and untrained healthy volunteers, obese and type 2 diabetic subjects
  2. to test the effects of a 8-weeks long individualized training program on these functions in obese subjects and in diabetics patients.

Study Overview

Status

Completed

Detailed Description

Obesity, especially in its truncal distribution, and type 2 diabetes, increase cardiovascular risk. Mechanisms underlaying both early preclinical, and clinical cardiovascular complications are complex and still incompletely clarified.

However, relationship between central, i.e. cardiac, and peripheral, i.e. vascular dysfunctions remains unclear, as well as their respective role in reduced exercise tolerance in these populations.

Moreover, exercise training can improve both metabolic status and cardiovascular risk, and thus, has proven useful in management and prevention of chronic metabolic diseases. Nevertheless, respective effects of training on cardiac and vascular functions, and on their interaction at rest, but also during exercise, need to be clarified.

Therefore, the aims of this study are :

  1. to compare cardiac and vascular functions at rest and during a local maximal leg exercise in 4 groups of age-matched men, without cardiovascular diseases but exhibiting increasing cardiovascular risk: trained and untrained healthy volunteers, obese and type 2 diabetic subjects
  2. to test the effects of a 8-weeks long individualized training program on these functions in obese subjects and in diabetics patients.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nimes
      • Nîmes, Nimes, France, 30029
        • Service d'Explorations et de Médecine Vasculaire University Hospital Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • non-diabetic obese subjects and type 2 diabetic subjects

Exclusion Criteria:

  • smoking
  • known peripheral artery insufficiency
  • heart failure
  • uncontrolled hypertension
  • thyroid disease
  • insulin dependent diabetes
  • for diabetics subjects : HbA1c > 10 %

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Study Population

non-diabetic obese subjects and type 2 diabetic subjects

Intervention: 8 weeks individualized training program

no drugs added

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Peripherical vascular function at rest and during exercise
Time Frame: before and after training
before and after training
cardiac function at rest and during exercise
Time Frame: before and after training (8 weeks)
before and after training (8 weeks)

Secondary Outcome Measures

Outcome Measure
Time Frame
metabolic profile (biological data)
Time Frame: before and after training (8 weeks)
before and after training (8 weeks)
body composition and BMI
Time Frame: before and after training (8 weeks)
before and after training (8 weeks)
VO2
Time Frame: before and after training (8 weeks)
before and after training (8 weeks)
substrate utilization during exercise
Time Frame: before and after training (8 weeks)
before and after training (8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonia Pérez-Martin, MD, PhD, University Hospital Center of Nimes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2005

Primary Completion (Actual)

December 31, 2010

Study Completion (Actual)

December 31, 2010

Study Registration Dates

First Submitted

December 12, 2005

First Submitted That Met QC Criteria

December 12, 2005

First Posted (Estimated)

December 13, 2005

Study Record Updates

Last Update Posted (Estimated)

November 17, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

March 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe